Topical Cannabis for Chronic Musculoskeletal Pain

NCT05908552 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2023-06-18

No results posted yet for this study

Summary

Our proposal objective is to evaluate if state-regulated topical CBD-based products relieve chronic musculoskeletal pain and/or absorb into the bloodstream.

Conditions

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Emily Lindley, PhD · University of Colorado, Denver

  • Rachael Rzasa Lynn, MD · University of Colorado, Denver

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-04-30
Completion
2024-08-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05908552 on ClinicalTrials.gov